Ruxolitinib and Steroid As First Line Therapy for Acute GVHD
Clinical trial NCT03701698 · TERMINATED
Trial details
- NCT number
- NCT03701698
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2024-09-20
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.